New Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Craig Palosky for Kaiser Family Foundation published August 9, 2023) Federal spending on bonus payments to insurance companies that
Read More(By Juliette Cubanski for the Kaiser Family Foundation published August 8, 2023) The Inflation Reduction Act of 2022 (the Act),
Read More(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read MoreThe Centers for Medicare & Medicaid Services (CMS) announced its new dementia care model. The model, Guiding an Improved Dementia
Read More(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation Published: Jul
Read More(By Leslie Walker and Dan Gorenstein for NPR) Drugmakers around the globe are bracing for a major shakeup in how
Read More(By Rylee Wilson for Becker’s Hospital Review ) Medicare Advantage enrollees who use supplemental benefits are more likely to live
Read More(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Jul 26, 2023) The Medicare Part D program provides
Read More(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read More